DRDO invites EoI to license Indian pharma companies to manufacture new drug.

Photo: The Financial Express

DRDO Invites EoI To Transfer Tech Of 2-DG Drug For Bulk Production

The DRDO created 2-Deoxy-D-Glucose (2-DG) has solicited Expression of Interest for the technology to be licensed to Indian pharmaceutical businesses for production. The drug was developed by a DRDO lab- the Institute of Nuclear Medicine and Allied Sciences in collaboration with Dr. Reddy Laboratories. Helping COVID patients for a faster recovery, the drug reduces dependency on medical oxygen. Notably, a higher number of patients treated with… read-more

Wed, 09 Jun 2021 - 07:47 PM / by Anvitha Shetty

Tags: DRDO, Dr Reddy's, Covid-19, Indian Pharma

Zydus Cadila

Photo: The News Minute

DCGI Nods Emergency Use Of Zydus Cadila's 'Virafin' For Moderate COVID-19

The Drugs Controller General of India on April 23 approved the emergency use of Zydus Cadila's Pegylated Interferon alpha-2b (PegIFN), ‘Virafin' to treat moderately infected COVID patients. Reportedly, Zydus claims that 91.5% of patients administered with this drug have shown fast recovery while requiring less oxygen for treatment. Interestingly, they also tested negative on RT-PCR test by day 7. India recorded 3.32 lakh fresh COVID-19 cases… read-more

Fri, 23 Apr 2021 - 07:28 PM / by Neha Sanjeev

Tags: Virafin, DCGI, Covid-19, drug, Indian Pharma

Courtesy: Times Now news

Janaushadhi Kendra

Photo: News18 Hindi

India to Have 10,500 Janaushadhi Kendras by 2025, Says Sadananda Gowda

Ministry of Chemicals and Fertilisers on September 17 revealed that it plans to have at least 10,500 'Pradhan Mantri Bharatiya Janaushadhi Kendras (PMBJK)' by 2025. Union Minister Sadananda Gowda said 10,500 PMBJKs would ensure that the service reaches every corner of the country. The PMBJK initiative aims at providing quality medicines at affordable rates. According to the ministry,… read-more

Fri, 18 Sep 2020 - 09:17 AM / by Sneha Ramesh

Tags: India, Indian Pharma, medicine, Central Government

Courtesy: The Economic Times

Covid-19 Drug

Photo: CGTN.com

Kochi-based Pharma Gets Approval to Start Phase-2 Trials for COVID-19 Drug

Central Licensing Authority, under the Central Drugs Standard Control Organization, has granted approval to Kochi-based pharma, PNB Vesper to begin phase-2 trials of a COVID-19 drug. The drug, 'PNB001', which is a new chemical entity (one that contains molecules which have never been approved by USFDA), is the first-of-its-kind to start phase-2 trials. According to… read-more

Sat, 12 Sep 2020 - 08:32 AM / by Sneha Ramesh

Tags: Covid-19, Coronavirus, coronavirus treatment, Kochi, Indian Pharma

Courtesy: The Economic Times


Photo: The Print

Favipiravir Tablet to be Available in 400mg for COVID-19 Treatment

BDR Pharmaceuticals has planned to launch 400mg Favipiravir tablets after approval from DCGI. It will cost Rs 990 for a strip of 10 'Favipiravir 400 mg' tablets. The Favipiravir tablets are currently available in 200 mg and are being used to treat COVID-19 patients with 'mild-symptoms'. "Introducing a higher… read-more

Sun, 06 Sep 2020 - 08:33 AM / by Sneha Ramesh

Tags: Indian Pharma, Coronavirus, Covid-19, Favipiravir

Courtesy: The Economic Times


Photo: The Financial Express

Andhra Government to Set up Bulk Drug Park; Signs MoU with CSIR-IICT

The Andhra Pradesh Industrial Infrastructure Corporation (APIIC) on September 03 signed a MoU with the CSIR-IICT to set up a Bulk Drug Park (BDP) in the state. As a knowledge partner, CSIR-IICT will provide technical inputs for preparing the blueprint of BDP. Earlier, the Centre had announced to extend grants-in-aid to states for development of three bulk drug and four medical device… read-more

Fri, 04 Sep 2020 - 08:50 AM / by Sneha Ramesh

Tags: Indian Pharma, Andhra Pradesh, Union government, APIs

Lab test conducted for anti-body drug

Photo: Washington Times

Companies Conduct Antibody Drug Tests to Combat COVID-19

Pharmaceutical companies are piercing through the idea of the infusion of a drug that delivers the antibodies to fight the coronavirus, without the immune system being trained to produce it. As an immediate effective alternate for the vaccine to combat the coronavirus, a lot of studies are being conducted in this regard. Reportedly, the dosage can be effective for a month or more to people at high risk of infection. 

Wed, 12 Aug 2020 - 07:05 PM / by Tania Mukhopadhyay

Tags: Covid-19, drug, Covid-19 Test, Indian Pharma

Courtesy: Hindustan Times